The GOLD guidelines definition of mild airway obstruction

Respiratory Care

Volumn 55, Issue 10, 2010, Pages 1397-1398

  Quanjer, Philip H ^a   Enright, Paul L ^b   Ruppel, Gregg L ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ARIZONA   (United States)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC PROCEDURE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE ORGANIZATION; HUMAN; LETTER; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PROGRAM DEVELOPMENT; PUBLICATION; SPIROMETRY;

EID: 78149381656     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (40)

1. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Official statement of the European Respiratory Society. Respir J Suppl 1993;16:5-40.
2. Falaschetti E, Laiho, Primatesta P, Purdon S. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004;23(3):456-463.
3. Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, et al. Reference ranges for spirometry across all ages: a new approach. AmJ Respir Crit Care Med 2008;177(3):253-260.
4. Quanjer PH. Download software for diagnosing airway obstruction, COPD, and for an exhaustive set of predicted values for FEV1, FVC, and FEV1/FVC and their lower limits of normal. Version 3.1.0.118. http://www.spirxpert.com/gold.html. Accessed August 6, 2010.
5. Quanjer PH. Do not adopt the GOLD definition. http://www.spirxpert.com/controversies/controversy.html Last updated September 10, 2009. Accessed August 6, 2010.
6. Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J 2010;36(1)12-19.
7. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Mørkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20(5):1117-1120.
8. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003;22(2):268-273.
9. Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, Wood KL. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006;130(1):200-206.
10. Aggarwal AN, Gupta D, Behera D, Jindal SK. Comparison of fixed percentage method and lower confidence limits for defining limits of normality for interpretation of spirometry. Respir Care 2006;(7)51:737-743.
11. Miller MR, Steenbruggen I, Quanjer PH, Ruppel G, Crapo RO, Pedersen OF. Defining the lower limit of normal for FEV1/FVC (letter). Am J Respir Crit Care Med 2007;176(1):101-102.
12. Miller MR. What defines abnormal lung function? (letter). Thorax 2007;62(2):1107.
13. Petsonk EL, Hnizdo E, Attfield M. Definition of COPD GOLD stage I (letter). Thorax 2007;62(3):1107-1108.
14. Medbø A, Melbye H. Lung function testing in the elderly: can we still use the FEV1/FVC_70%as a criterion for COPD? Respir Med 2007;101(6):1097-1105.
15. Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007;30(2):232-239.
16. Vollmer WM, Gíslason B, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009;34(3):588-597.
17. Miller MR, Pedersen OF, Pellegrino R, Brusasco V. Debating the definition of airflow obstruction: time to move on? (editorial). Eur Respir J 2009;34(3):527-528.
18. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008;63(12):1046-1051.
19. Olofson J, Bake B, Tengelin MN, Houltz B. COPD 'diagnosis' based on spirometric reference equations. Clin Respir J 2008;2(4):214-219.
20. Ko FW, Woo J, Tam W, Lai CK, Ngai J, Kwok T, Hui DS. Prevalence and risk factors of airflow obstruction in an elderly Chinese population. Eur Respir J 2008;32(6):1472-1478.
21. Lau AC, Ip MS, Lai CK, Choo KL, Tang KS, Yam LY, Chan-Yeung M. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest 2008;133(1):42-48.
22. Schermer TR, Smeele IJ, Thoonen BP, Lucas AE, Grootens JG, van Boxem TJ, et al. Current clinical guideline definitions for airflow obstruction leads to substantial overdiagnosis of COPD in primary care. Eur Respir J 2008;32(4):945-952.
23. Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small I. Diagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Prim Care Respir J 2009;18(3):130-147.
24. Schermer TR, Quanjer PH. COPD screening in primary care: who is sick? Prim Care Respir J 2007;16(1):49-53.
25. Pérez-Padilla R, Hallal PC, Vázquez-García JC, Muiño A, Máquez M, López MV, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. Int J COPD 2007;4(2):113-120.
26. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(5):446-451.
27. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80 percent of predicted and 5 fixed thresholds misclassifies over 20% of patients. Chest 2010 [epub ahead of print]. DOI: 10.1378/chest.10-0189.
28. Enright PL. GOLD stage I is not a COPD risk factor (letter). Thorax 2007;62(12):1107-1109.
29. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988;43(4):265-267.
30. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. AmRev Respir Dis 1991;144(5):1202-1218.
31. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.
32. Townsend MC. Conflicting definitions of airways obstruction: drawing the line between normal and abnormal (editorial). Chest 2007;131(2):335-336.
33. Kerstjens HA. TheGOLDclassification has not advanced understanding of COPD (editorial). Am J Respir Crit Care Med 2004;170(3):212-214.
34. Enright P, Quanjer P. Don't diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator (editorial). Int J COPD 2007;4(2):89-90.
35. Culver BH. Interpretation of spirometry: we can do better than the GOLD standard (editorial). Respir Care 2006;51(7):719-721.
36. Agency for Healthcare Research and Quality; Wilt T, Niewoehner DE, Kim CB. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evidence report/technology assessment 121. AHRQ Publication 05-E017-2; 2005.
37. Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006;3(2):95-100.
38. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction. Use percentage of FEV1/FVC ratio below the fifth percentile, not _ 70%. Chest 2007;131(2):349-355.
39. Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Antó JM, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC _70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008;63(12):1040-1045.
40. Cerveri I, Corsico AG, Accordini S, Ansaldo E, Grosso A, Niniano R, et al. What defines airflow obstruction in asthma? Eur Respir J 2009;34(3):568-573.